Research output per year
Research output per year
Personal profile
Research areas
Incretin-based therapy in type 1 diabetes as well as insulins. Gestational diabetes mellitus.
Main research areas
Incretin-based therapy in type 1 diabetes as well as insulins. Gestational diabetes mellitus.
Current research
The MAG1C Trial: Meal-time administration of exenatid for glycaemic control in type 1 diabete: A randomized, double-blinded, placebo-controlled trial
Metabolomic analysis of GDM and NGT pregnant women.
Potential conflicts of interest
Minor travel grant from AstraZeneca in 2017.
Fingerprint
Dive into the research topics where Nicklas Järvelä Johansen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Dasiglucagon corrects postprandial hypoglycaemia in roux-en-y gastric bypass-operated individuals
Nielsen, C. K., Houji, I., Øhrstrøm, C. C., Helsted, M. M., Krogh, L. S. L., Johansen, N. J., Vilsbøll, T. & Knop, F. K., 21 Feb 2023, In: Diabetes Technology and Therapeutics. 25, S2, 326.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Dasiglucagon corrects postprandial hypoglycaemia in Roux-en-Y gastric bypass-operated individuals
Nielsen, C., Ohrstrom, C., Houji, I., Helsted, M., Krogh, L., Johansen, N., Hartmann, B., Holst, J., Vilsboll, T. & Knop, F., 1 Sept 2023, In: Diabetologia. 66, SUPPL 1, 1, p. S380-S381Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial
Nielsen, C. K., Øhrstrøm, C. C., Houji, I. J. K., Helsted, M. M., Krogh, L. S. L., Johansen, N. J., Hartmann, B., Holst, J. J., Vilsbøll, T. & Knop, F. K., 1 Dec 2023, In: Diabetes Care. 46, 12, p. 2208-2217 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes
Johansen, N. J. & Knop, F. K., 2 Jun 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 4, p. 311-317 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus) -
Effects of short-acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes
Johansen, N. J., Dejgaard, T. F., Lund, A., Schlüntz, C., Hartmann, B., Holst, J. J., Vilsbøll, T., Andersen, H. U. & Knop, F. K., Feb 2022, In: Diabetes, Obesity and Metabolism. 24, 2, p. 221-227 7 p.Research output: Contribution to journal › Journal article › Research › peer-review